DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.614 EUR
-0.05 (-0.72%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • CPR had positive earnings in the past year.
  • CPR had a positive operating cash flow in the past year.
  • In the past 5 years CPR has always been profitable.
  • Each year in the past 5 years CPR had a positive operating cash flow.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.27%, CPR is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 8.97%, CPR is in line with its industry, outperforming 48.15% of the companies in the same industry.
  • CPR has a Return On Invested Capital of 6.57%. This is in the better half of the industry: CPR outperforms 62.96% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.49%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR has a better Profit Margin (11.35%) than 62.96% of its industry peers.
  • In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
  • CPR has a Operating Margin of 19.74%. This is in the better half of the industry: CPR outperforms 62.96% of its industry peers.
  • CPR's Operating Margin has improved in the last couple of years.
  • CPR's Gross Margin of 60.31% is amongst the best of the industry. CPR outperforms 85.19% of its industry peers.
  • CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CPR.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPR is still creating some value.
  • CPR has less shares outstanding than it did 1 year ago.
  • CPR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CPR has an improved debt to assets ratio.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.72 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CPR has a Altman-Z score of 2.72. This is in the better half of the industry: CPR outperforms 77.78% of its industry peers.
  • The Debt to FCF ratio of CPR is 6.60, which is on the high side as it means it would take CPR, 6.60 years of fcf income to pay off all of its debts.
  • CPR has a better Debt to FCF ratio (6.60) than 66.67% of its industry peers.
  • CPR has a Debt/Equity ratio of 0.59. This is a neutral value indicating CPR is somewhat dependend on debt financing.
  • CPR has a better Debt to Equity ratio (0.59) than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.72
ROIC/WACC0.99
WACC6.66%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • CPR has a Current Ratio of 2.22. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
  • CPR has a better Current ratio (2.22) than 77.78% of its industry peers.
  • A Quick Ratio of 0.96 indicates that CPR may have some problems paying its short term obligations.
  • The Quick ratio of CPR (0.96) is better than 81.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CPR.MI Growth Analysis

3.1 Past

  • CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
  • CPR shows a decrease in Revenue. In the last year, the revenue decreased by -0.60%.
  • CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.48% yearly.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.76% yearly.
  • Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 3.30% on average per year.
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue Next Year0.49%
Revenue Next 2Y2.55%
Revenue Next 3Y3.39%
Revenue Next 5Y3.3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 22.81, which indicates a rather expensive current valuation of CPR.
  • CPR's Price/Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 62.96% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.18. CPR is around the same levels.
  • The Price/Forward Earnings ratio is 20.98, which indicates a rather expensive current valuation of CPR.
  • CPR's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.96, CPR is valued a bit cheaper.
Industry RankSector Rank
PE 22.81
Fwd PE 20.98
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.
  • CPR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.97
EV/EBITDA 13.37
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.17
PEG (5Y)1.89
EPS Next 2Y8.37%
EPS Next 3Y9.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • CPR has a Yearly Dividend Yield of 1.51%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.76, CPR is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, CPR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 22.52% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP22.52%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (4/13/2026, 7:00:00 PM)

6.614

-0.05 (-0.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners50.82%
Ins Owner ChangeN/A
Market Cap8.14B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts73.33
Price Target7.29 (10.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.58%
PT rev (3m)3.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-3.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE 22.81
Fwd PE 20.98
P/S 2.67
P/FCF 20.97
P/OCF 11.84
P/B 2.11
P/tB 20.53
EV/EBITDA 13.37
EPS(TTM)0.29
EY4.38%
EPS(NY)0.32
Fwd EY4.77%
FCF(TTM)0.32
FCFY4.77%
OCF(TTM)0.56
OCFY8.44%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)5.17
PEG (5Y)1.89
Graham Number4.52
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.72
F-Score8
WACC6.66%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year0.49%
Revenue Next 2Y2.55%
Revenue Next 3Y3.39%
Revenue Next 5Y3.3%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year24.97%
EBIT Next 3Y12.76%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 22.81 and the Price/Book (PB) ratio is 2.11.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 4.41% in the next year.